The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis
Main Authors: | D Symmons, K Tricker, C Roberts, L Davies, P Dawes, D Scott |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2005-09-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta9340 |
Similar Items
-
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial.
by: Symmons, D, et al.
Published: (2006) -
The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis.
by: Harrison, M, et al.
Published: (2005) -
Rheumatoid arthritis: A major symptom and symptomatic therapy
by: Yuri Aleskandrovich Olyunin
Published: (2014-12-01) -
The overall status in rheumatoid arthritis (OSRA) measure--further evidence to support its use in clinical practice.
by: Harrison, M, et al.
Published: (2007) -
Pre-symptomatic autoimmunity in rheumatoid arthritis: When does the disease start?
by: Tracy, A, et al.
Published: (2017)